Hepatic

INDICATION: Liver disease

Cell culture and mouse studies suggest liver-targeted TGFBR1 gene therapy could help treat Alagille syndrome, a genetic

Read the full 197 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE